suprofen

Also known as Profenal®, R-25061, (+-)-2-(p-(2-thenoyl)phenyl)propionic acid, alpha-methyl-4-(2-thienylcarbonyl)benzeneacetic acid, p-2-thenoylhydratropic acid, 2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid, Suprofène, Suprofene

Suprofen is a nonsteroidal anti-inflammatory drug (NSAID) developed by Janssen Pharmaceutica that was marketed as 1% eye drops under the trade name Profenal.

Research

320 papers

Suprofen. A review of its pharmacodynamic and pharmacokinetic properties, and analgesic efficacy.Drugs · 1985
Introduction to the pharmacology of suprofen.Pharmacology · 1983
Suprofen.The Medical letter on drugs and therapeutics · 1986
Suprofen: the pharmacology and clinical efficacy of a new non-narcotic peripheral analgesic.Clinics in rheumatic diseases · 1984
Suprofen, a new peripheral analgesic.The Journal of pharmacology and experimental therapeutics · 1980

via PubMed

Article

2 sections

Contents

Uses
References

Suprofen is a nonsteroidal anti-inflammatory drug (NSAID) developed by Janssen Pharmaceutica that was marketed as 1% eye drops under the trade name Profenal.

==Uses== Suprofen was originally used as tablet, but oral uses have been discontinued due to renal effects. It was subsequently used exclusively as a topical ophthalmic solution, typically to prevent miosis during and after ophthalmic surgery. This application has been discontinued as well, at least in the US.